Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
339 Leser
Artikel bewerten:
(2)

Doceree Inc.: Doceree launches RepTwin--an unprecedented AI-powered innovation, set to redefine HCP-rep interactions

Doceree launches its unique AI-powered solution at Fierce Pharma Week 2025, empowering pharma manufactures and marketers with the first-of-its-kind ad format that makes brand reps available to physicians 24/7.

PHILADELPHIA, Sept. 9, 2025 /PRNewswire/ -- Doceree, the only AI-powered operating system for healthcare marketing, today announced the launch of RepTwin, the first AI-powered ad format that transforms healthcare professional (HCP) engagement by making brand representatives virtually available to HCPs anytime, anywhere, within their daily workflows. Announced at Fierce Pharma Week 2025, RepTwin launch unlocks the Conversation Layer, ushering in a new era of HCP-rep engagement.

As access to in-person brand reps continues to decline-65% of physicians now restrict rep access and facetime with brand reps in the U.S. averages just a few minutes-RepTwin offers an innovative solution. By embedding a compliant, on-demand virtual rep into electronic health record (EHR) platforms, specialist medical publishers, and other digital environments, Doceree ensures physicians can now access brand information and clinical support when and where they need.

Doceree launches RepTwin-an unprecedented AI-powered innovation, set to redefine HCP-rep interactions

Announcing the solution, Harshit Jain, MD, Founder & Global CEO of Doceree, said, "For too long, our industry has viewed AI merely as a tool for performance and impression optimization-we believe its potential goes far beyond that. With RepTwin, we are proving exactly that. RepTwin will redefine how brands connect with physicians. For the first time, HCPs can engage with a fully trained, compliant, and always-available virtual brand rep-on their own terms and within their own workflows."

Key features of RepTwin are:

  • Always available, everywhere - Accessible 24/7 across EHRs, specialist medical publishers, brand websites, and training platforms.
  • Brand-trained & continuously updated - Aligned with clinical trial data, marketing content, brand voice, competition and regulatory standards.
  • Built-in compliance - HIPAA, GDPR, SOC2, PHI-compliant and MLR-approved responses from day one.
  • Multi-modal interaction - Natural conversations via video, voice and text, based on HCP preference.
  • Most relevant engagement - Appears only when clinically relevant HCP, such as during patient consultations or while researching on medical publishers.

With direct integrations across 2,000+ specialist medical publishers, 150+ EHRs (including Epic & Cerner), and a network of over 6 million verified HCPs, RepTwin is set to deliver hyper-personalized engagement and credible support to HCPs at scale.

"Physician accessibility has for long been a challenge for brands and their reps. RepTwin aims to solve this with an AI-powered ad format that comes with built-in compliance, personalization, and accessibility," added Harshit Jain, MD.

Extending its ongoing ad campaign, Doceree also launched an AI-generated ad film for RepTwin, capturing an HCP's acknowledgment of the value an always-available brand rep brings to support him during critical clinical decision-making-delivered once again with Doceree's signature mix of creativity and quirky flair. Watch full film here: https://youtu.be/d5kVclCbOHE

RepTwin is available for pharmaceutical manufacturers and life sciences brands seeking to modernize their HCP engagement strategies with Doceree's AI-powered Operating System. Learn more: https://doceree.com/reptwin/

About Doceree

Doceree is the only AI-powered Operating System for healthcare marketing. We believe the role of AI is to bring richer context to every HCP interaction. Hence, our patented AI understands multiple layers of context to enhance every HCP interaction in a privacy-compliant manner, delivering measurably better outcomes every time. In just five years, we have emerged as leaders in AI-powered, hyper-personalized healthcare messaging - redefining HCP engagement with more powerful context and more powerful outcomes.

For more information visit https://doceree.com/

Photo - https://mma.prnewswire.com/media/2768956/Doceree_launches_RepTwin.jpg
Logo - https://mma.prnewswire.com/media/1758952/Doceree_Logo.jpg

Doceree Logo

Cision View original content:https://www.prnewswire.co.uk/news-releases/doceree-launches-reptwinan-unprecedented-ai-powered-innovation-set-to-redefine-hcp-rep-interactions-302551111.html

© 2025 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.